Secondary hematologic malignancies associated with temozolomide (TMZ) in patients with glioma.

被引:1
|
作者
Momota, H.
Narita, Y.
Miyakita, Y.
Shibui, S.
机构
[1] Nagoya Univ, Nagoya, Aichi 4648601, Japan
[2] Natl Canc Ctr, Tokyo, Japan
关键词
D O I
10.1200/jco.2010.28.15_suppl.2046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2046
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Hematologic malignancies in elderly patients
    Hassan, Moustapha
    Abedi-Valugerdi, Manuchehr
    HAEMATOLOGICA, 2014, 99 (07) : 1124 - 1127
  • [42] Cholecystectomy in patients with hematologic malignancies
    Stewart, Camille L.
    Tran, Thuy B.
    Nguyen, Andrew
    Zain, Jasmine
    Lai, Lily
    Fong, Yuman
    Woo, Yanghee
    AMERICAN JOURNAL OF SURGERY, 2022, 223 (06): : 1157 - 1161
  • [43] Clinicopathologic Characteristics Of Secondary Malignancies In Survivors Of Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Malignancies
    Chaulagain, Chakra P.
    Kaul, Esha
    Pilichowska, Monika
    Klein, Andreas K.
    Sprague, Kellie
    Miller, Kenneth B.
    BLOOD, 2013, 122 (21)
  • [44] Coccidioidomycosis in patients with hematologic malignancies
    Blair, JE
    Smilack, JD
    Caples, SM
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (01) : 113 - 117
  • [45] Toxoplasmosis in patients with hematologic malignancies
    Chintakuntlawar, Ashish
    Kidd, Michael
    Al-Kali, Aref
    Wilson, Walter
    Thompson, Carrie A.
    LEUKEMIA & LYMPHOMA, 2015, 56 (02) : 536 - 538
  • [46] Paraneoplastic Glomerulopathies Associated with Hematologic Malignancies
    Dhanapriya, Jeyachandran
    Dineshkumar, Thanigachalam
    Sakthirajan, Ramanathan
    Surendar, Dhanikachalam
    Gopalakrishnan, Natarajan
    Balasubramaniyan, T.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2018, 29 (02) : 452 - 455
  • [47] Toxicities associated with immunotherapies for hematologic malignancies
    Leick, Mark B.
    Maus, Marcela V.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (02) : 158 - 165
  • [48] A study comparing temozolomide (TMZ) before CTRT versus standard treatment in high grade glioma
    De Sarkar, Shubha
    Dastidar, Aloke Ghosh
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S845 - S847
  • [49] Phase I study of sorafenib in combination with radiation therapy and temozolomide for the first-line treatment of patients with high grade glioma.
    Hottinger, A. F.
    Ben Aissa, A.
    Bodmer, A.
    Squiban, D.
    Dunkel, N.
    Maradan, N.
    Vargas, M. I.
    Weber, D. C.
    Brendel, E.
    Dietrich, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Symptom clusters in patients with high-grade glioma.
    Fox, Sherry
    Lyon, Debra
    Farace, Elana
    ONCOLOGY NURSING FORUM, 2007, 34 (01) : 213 - 213